MD1166Y - Method for testing donor blood for viral hepatitis B markers - Google Patents
Method for testing donor blood for viral hepatitis B markersInfo
- Publication number
- MD1166Y MD1166Y MDS20170004A MDS20170004A MD1166Y MD 1166 Y MD1166 Y MD 1166Y MD S20170004 A MDS20170004 A MD S20170004A MD S20170004 A MDS20170004 A MD S20170004A MD 1166 Y MD1166 Y MD 1166Y
- Authority
- MD
- Moldova
- Prior art keywords
- markers
- blood
- viral hepatitis
- donor blood
- testing
- Prior art date
Links
- 239000008280 blood Substances 0.000 title abstract 6
- 210000004369 blood Anatomy 0.000 title abstract 6
- 208000002672 hepatitis B Diseases 0.000 title abstract 3
- 241000700721 Hepatitis B virus Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to medicine and can be used for testing donor blood for viral hepatitis B markers in order to prevent infection in the case of blood transfusion.Summary of the invention consists in that the presence of HBsAg antigen, total anti-HBcor, anti-HBcor IgM and anti-HBs antibodies is sequentially determined in the blood, and for the blood with an anti-HBs titer greater than 100 mIU/ml, a hepatitis B virus DNA test is additionally performed and in the case of a positive test, the presence of viral hepatitis B markers in the donor blood is determined.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20170004A MD1166Z (en) | 2017-01-19 | 2017-01-19 | Method for testing donor blood for viral hepatitis B markers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20170004A MD1166Z (en) | 2017-01-19 | 2017-01-19 | Method for testing donor blood for viral hepatitis B markers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1166Y true MD1166Y (en) | 2017-07-31 |
| MD1166Z MD1166Z (en) | 2018-02-28 |
Family
ID=59383898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20170004A MD1166Z (en) | 2017-01-19 | 2017-01-19 | Method for testing donor blood for viral hepatitis B markers |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1166Z (en) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU712091A1 (en) * | 1978-07-31 | 1980-01-30 | Рижский Медицинский Институт | Method of detecting antigens or antibodies e of hepatitis b viruses |
| DE3705512A1 (en) * | 1987-02-20 | 1988-09-01 | Seelig Renate | Virus antigen, process for obtaining it and use in diagnosis and therapy (vaccine) |
| SU1642399A1 (en) * | 1988-12-27 | 1991-04-15 | Институт Органического Синтеза Ан Латвсср | Method for determination of antibodies class igm for corantigen of hepatitis b virus |
| SU1704088A1 (en) * | 1989-06-27 | 1992-01-07 | Нижегородский государственный медицинский институт им.С.М.Кирова | Method for forecasting chronic viral hepatitis b |
| SU1751680A1 (en) * | 1990-03-11 | 1992-07-30 | Нижегородский медицинский институт им.С.М.Кирова | Method for prognostication of chronic hepatitis b development |
| MD34Z5 (en) * | 2008-05-20 | 2010-01-31 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Method for diagnosing the viral hepatitis B to babies of up to one year |
| MD975Z (en) * | 2015-01-28 | 2016-07-31 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Method for donor blood testing for hepatitis B virus markers |
-
2017
- 2017-01-19 MD MDS20170004A patent/MD1166Z/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD1166Z (en) | 2018-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Banatvala et al. | Hepatitis B vaccine–do we need boosters? | |
| Gisbert et al. | Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease | |
| Tsoi et al. | Enhanced detection of hepatitis B virus in H ong K ong blood donors after introduction of a more sensitive transcription‐mediated amplification assay | |
| Arnold et al. | Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia | |
| Coppola et al. | HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient | |
| Alizadeh et al. | Occult hepatitis B virus infection among Iranian blood donors: a preliminary study | |
| Kose et al. | Seroprevalence of hepatitis B and C among oncology patients in Turkey | |
| Khamesipour et al. | Frequency of hepatitis B virus DNA in anti-HBc positive, HBsAg negative blood donors in Rasht, northern Iran | |
| Bogler et al. | Epidemiology and natural history of chronic hepatitis B virus infection | |
| MD975Z (en) | Method for donor blood testing for hepatitis B virus markers | |
| MD1166Z (en) | Method for testing donor blood for viral hepatitis B markers | |
| Aghasadeghi et al. | No evidence for occult HBV infection in hepatitis B vaccine non-responders | |
| Rezahosseini et al. | Torque-Teno virus to optimize timing of vaccination against severe acute respiratory syndrome coronavirus 2 in solid organ transplant recipients | |
| Genet et al. | Prevalence of monoclonal gammopathy in HIV patients in 2014 | |
| Al Jadiry et al. | High incidence of hepatitis B infection after treatment for paediatric cancer at a teaching hospital in Baghdad | |
| Kalantari et al. | Prevalence of hepatitis C virus, hepatitis B virus, human immunodeficiency virus and related risk factors among hemophilia and thalassemia patients In Iran | |
| Chakraborty et al. | Persistence of anti-HBs antibody and immunological memory in healthy individuals vaccinated with Hepatitis B vaccine | |
| Rinaldi et al. | B-sides serologic markers of immunogenicity in kidney transplanted patients: report from 2012–2013 flu vaccination experience | |
| Leung et al. | A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT. | |
| Aggarwal et al. | Prevalence of hepatitis B and hepatitis C infections in patients and healthy blood Donors | |
| De Paschale et al. | Presence of anti-HBs antibodies in blood donors 18–22 years after vaccination and implications for the selection of candidates for plasmapheresis for the production of hyperimmune plasma | |
| Atalay et al. | Hepatitis B and C Sero-prevalence in Patients with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome at a Tertiary Care Hospital in Izmir | |
| Huh et al. | Improvement of the Accuracy of Hepatitis B Surface Antigen Testing Using a Confirmatory Test | |
| Smith | Hepatitis A hepatitis B vaccine | |
| Insulander et al. | Evaluation of a new vaccination program for infants born to HBsAg-positive mothers in Stockholm County |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued | ||
| MK4Y | Short term patent expired |